Z Squared ZSQR
NASDAQ ZSQR
$3.91 -0.04 (-1.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

Z Squared (ZSQR) EBIT Margin (2025 - 2026)

Updated

Z Squared's EBIT Margin was -871.15% in Q2 2026, up 2569.66 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) EBIT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's EBIT Margin was -792.87% through Jun 30, 2026, up 12505.13 percentage points year-over-year; for FY2025, it was -956.94%.

  • EBIT Margin shows a four-year change of +17770.97 percentage points (FY2021 to FY2025).
  • In earlier years, EBIT Margin was -18727.91% in FY2021.
  • Quarterly EBIT Margin has moved between -6452.56% (Q1 2025) and -230.64% (Q4 2025) over five years.
  • Per Business Quant data, ZSQR's EBIT Margin in the three quarters before Q2 2026 was -3440.81% (Q1 2026), -230.64% (Q4 2025) and -1043.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Z Squared 194.06 Mn 167.30 Mn -1.77 Mn -871.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -871.15%
Mar 31, 2026 -3,440.81%
Dec 31, 2025 -230.64%
Sep 30, 2025 -1,043.22%
Mar 31, 2025 -6,452.56%
API Access

Z Squared EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY